Lataa...
Concurrent inhibition of ErbB family and MEK/ERK kinases to suppress non-small cell lung cancer proliferation
Lung cancer ranks as the most common cancer and leading cause of cancer-related deaths worldwide. Of all lung cancer types, non-small cell lung cancer (NSCLC) accounts for 85 percent of all cases. The high mortality of NSCLC occurs mainly because of poor prognosis in patients with recurrent and meta...
Tallennettuna:
| Julkaisussa: | Am J Transl Res |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
e-Century Publishing Corporation
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7137063/ https://ncbi.nlm.nih.gov/pubmed/32269717 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|